Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2023-06-08 Sale | 2023-06-12 4:16 pm | Pacira BioSciences Inc. | PCRX | Kronenfeld Mark A. Director | 15,000 | $37.04 | $555,600 | 17,897 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-06-12 Option Award | 2024-06-13 6:12 pm | 2025-06-12 2034-06-12 | Pacira BioSciences Inc. | PCRX | Kronenfeld Mark A. Director | 17,409 | $0 | 37,081 (Direct) | View |
2023-06-14 Option Award | 2023-06-16 5:34 pm | 2024-06-14 2033-06-14 | Pacira BioSciences Inc. | PCRX | Kronenfeld Mark A. Director | 14,700 | $0 | 32,597 (Direct) | View |
2023-06-08 Exercise | 2023-06-12 4:16 pm | N/A 2023-06-11 | Pacira BioSciences Inc. | PCRX | Kronenfeld Mark A. Director | 15,000 | $0 | 17,897 (Direct) | View |
2023-06-08 Exercise | 2023-06-12 4:16 pm | N/A N/A | Pacira BioSciences Inc. | PCRX | Kronenfeld Mark A. Director | 15,000 | $29.9 | 17,897 (Direct) | View |
2022-06-08 Option Award | 2022-06-08 7:29 pm | 2023-06-08 2032-06-08 | Pacira BioSciences Inc. | PCRX | Kronenfeld Mark A. Director | 9,385 | $0 | 26,122 (Direct) | View |
2021-06-09 Option Award | 2021-06-11 8:33 pm | 2022-06-09 2031-06-09 | Pacira BioSciences Inc. | PCRX | Kronenfeld Mark A. Director | 8,692 | $0 | 24,363 (Direct) | View |
2020-06-09 Option Award | 2020-06-11 6:26 pm | 2021-06-09 2030-06-09 | Pacira BioSciences Inc. | PCRX | Kronenfeld Mark A. Director | 9,287 | $0 | 23,698 (Direct) | View |